Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Drewry

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
Scientific Reports|September 28, 2020
PKIS deep dive yields a chemical starting point for dark kinases and a cell active BRSK2 inhibitorTigist Y Tamir, David H Drewry, Carrow Wells, et al.
Cell Reports. Medicine|October 25, 2021
Host-directed therapy, an untapped opportunity for antimalarial interventionLing Wei, Jack Adderley, Didier Leroy, et al.
ACS Chemical Neuroscience|May 29, 2020
Defining the Neural Kinome: Strategies and Opportunities for Small Molecule Drug Discovery to Target Neurodegenerative DiseasesAndrea I Krahn, Carrow Wells, David H Drewry, et al.
International Journal of Molecular Sciences|October 29, 2020
Crystal Structure and Inhibitor Identifications Reveal Targeting Opportunity for the Atypical MAPK Kinase ERK3Martin Schröder, Panagis Filippakopoulos, Martin P Schwalm, et al.
ACS Chemical Biology|June 30, 2020
Identifying the Target of an Antiparasitic Compound in <i>Toxoplasma</i> Using Thermal Proteome ProfilingAlice L Herneisen, Saima M Sidik, Benedikt M Markus, et al.
Bioorganic & Medicinal Chemistry Letters|May 9, 2006
Array synthesis of progesterone receptor antagonists: 3-aryl-1,2-diazepinesRobert W Wiethe, Eugene L Stewart, David H Drewry, et al.
Plos One|March 19, 2013
Profile of the GSK published protein kinase inhibitor set across ATP-dependent and-independent luciferases: implications for reporter-gene assaysPatricia Dranchak, Ryan MacArthur, Rajarshi Guha, et al.
The Biochemical Journal|August 29, 2023
How many kinases are druggable? A review of our current understandingBrian Anderson, Peter Rosston, Han Wee Ong, et al.
Current Medicinal Chemistry|March 22, 2021
Targeting Never-In-Mitosis-A Related Kinase 5 in Cancer: A ReviewMargarite D Matossian, Carrow I Wells, William J Zuercher, et al.
The Journal of Biological Chemistry|August 20, 2017
A screen for kinase inhibitors identifies antimicrobial imidazopyridine aminofurazans as specific inhibitors of the <i>Listeria monocytogenes</i> PASTA kinase PrkAAdam J Schaenzer, Nathan Wlodarchak, David H Drewry, et al.
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Scientific Reports|September 28, 2020
PKIS deep dive yields a chemical starting point for dark kinases and a cell active BRSK2 inhibitorTigist Y Tamir, David H Drewry, Carrow Wells, et al.
Cell Reports. Medicine|October 25, 2021
Host-directed therapy, an untapped opportunity for antimalarial interventionLing Wei, Jack Adderley, Didier Leroy, et al.
ACS Chemical Neuroscience|May 29, 2020
Defining the Neural Kinome: Strategies and Opportunities for Small Molecule Drug Discovery to Target Neurodegenerative DiseasesAndrea I Krahn, Carrow Wells, David H Drewry, et al.
International Journal of Molecular Sciences|October 29, 2020
Crystal Structure and Inhibitor Identifications Reveal Targeting Opportunity for the Atypical MAPK Kinase ERK3Martin Schröder, Panagis Filippakopoulos, Martin P Schwalm, et al.
ACS Chemical Biology|June 30, 2020
Identifying the Target of an Antiparasitic Compound in <i>Toxoplasma</i> Using Thermal Proteome ProfilingAlice L Herneisen, Saima M Sidik, Benedikt M Markus, et al.
Bioorganic & Medicinal Chemistry Letters|May 9, 2006
Array synthesis of progesterone receptor antagonists: 3-aryl-1,2-diazepinesRobert W Wiethe, Eugene L Stewart, David H Drewry, et al.
Plos One|March 19, 2013
Profile of the GSK published protein kinase inhibitor set across ATP-dependent and-independent luciferases: implications for reporter-gene assaysPatricia Dranchak, Ryan MacArthur, Rajarshi Guha, et al.
The Biochemical Journal|August 29, 2023
How many kinases are druggable? A review of our current understandingBrian Anderson, Peter Rosston, Han Wee Ong, et al.
Current Medicinal Chemistry|March 22, 2021
Targeting Never-In-Mitosis-A Related Kinase 5 in Cancer: A ReviewMargarite D Matossian, Carrow I Wells, William J Zuercher, et al.
The Journal of Biological Chemistry|August 20, 2017
A screen for kinase inhibitors identifies antimicrobial imidazopyridine aminofurazans as specific inhibitors of the <i>Listeria monocytogenes</i> PASTA kinase PrkAAdam J Schaenzer, Nathan Wlodarchak, David H Drewry, et al.
Pageof 12